News Channels
|
 World Pharma News RSS Channel
 Subscribe to World Pharma News by Email
Follow us on: |
Research & Development
Conferences & Events
- Safety Biomarkers in Drug Development Conference to be held in Bratislava, Slovak Republic
- 4th Annual Clinical Site Partnerships in Central & Eastern Europe, to be held in Budapest, Hungary
- Physicians Go Digital Across the Globe - Webinar May 19
- Emerging Superpowers of Clinical Research - Russia, India, China
Financial
Product
- IRESSA (Gefitinib) Receives Marketing Authorisation in Europe
- AstraZeneca Development Partner, Pozen, Inc., Submits New Drug Application for PN400
- Lundbeck receives FDA Complete Response Letter on Serdolect® for the treatment of schizophrenia
- New biological therapy Ilaris® approved in US
- Nycomed receives Marketing Authorization for Pantoprazole 20mg OTC from European Commission
Clinical Trials
- Lu AA24530 shows positive results in major depressive disorder phase II study
- Schering-Plough Announces Phase II and III Data for Corifollitropin Alfa
- Pfizer Discontinues Phase 3 Trial of Sutent® in Metastatic Colorectal Cancer
- Sutent Significantly Improved Progression-Free Survival
- Abbott Initiates Trial of Next-Generation XIENCE PRIME(TM) Drug Eluting Stent
Corporate
- Graceway Pharmaceuticals Acquires Early-stage Dermatological Molecules from Pfizer
- Bayer files patent infringement lawsuit against Teva
- Bayer Schering Pharma Extends Research Portfolio in the Field of Cancer-Related Targets
- Novo Nordisk reaches settlement with the Danish authorities regarding Oil-for-Food activities
- GSK and Chroma Therapeutics form alliance to develop novel macrophage-targeted drugs